Heart tech company Capstan Medical announced on 9 August it raised $31.4m in a series B round of funding, led by venture capital firm Eclipse with participating investors including Intuitive Ventures and Puma Venture Capital.
The Santa Cruz, CA-based company plans to use the newly raised monies to expand its engineering, clinical development and operations teams in preparation for human trials of Capstan’s technology for...